论文部分内容阅读
我室曾以HAP—DOM方案治疗急非淋29例CR率75.9％,PR率6.9％.获得高缓解率的关键是化疗的药物与大剂量,早期使用骨髓增生程度降至低下,容易达到CR.化疗需使外周血白细胞降至1.0—1％左右,患者的骨髓增生情况才能较普遍地达到低下的程度.测定MBDI则不仅指导化疗,也有预报疗效的价值。
My room had HAP-DOM program for the treatment of acute Fei Lin CR rate of 75.9%, PR rate of 6.9% .High resolution rate of the key to the drug and high dose chemotherapy, early use of bone marrow reduced to a low degree, easy to reach CR Chemotherapy requires peripheral blood leukocytes down to about 1.0-1%, the degree of myeloproliferation in patients with bone marrow can be reached more generally low.Detecting MBDI not only guide the chemotherapy, but also predict the value of the efficacy.